Formula Growth’s Alignment Healthcare ALHC Stock Holding History

Formula Growth’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.21M	Sell	239,208 -300	-0.1%	-$6.03K	1.9%	7
2025 Q4	$4.73M	Sell	239,508 -8,700	-4%	-$156K	1.82%	10
2025 Q3	$4.33M	Buy	248,208 +67,000	+37%	+$993K	1.54%	17
2025 Q2	$2.54M	Buy	181,208 +51,208	+39%	+$825K	0.96%	40
2025 Q1	$2.42M	Buy	+130,000	New	+$1.94M	0.98%	42
2023 Q1	–	Sell	-190,400	Closed	-$2.24M	–	130
2022 Q4	$2.24M	Buy	+190,400	New	+$2.32M	0.63%	63

Other funds holding ALHC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Formula Growth's ALHC Position: Q1 2026 in Review

Formula Growth reduced its Alignment Healthcare (ALHC) stake by 0.13% in Q1 2026, selling an estimated $6.03K and leaving 239,208 shares worth $4.21M. The position accounts for 1.9% of the portfolio, ranked #7.

Formula Growth first reported a position in ALHC in Q4 2022 and has held it in 6 quarters since. The position peaked at $4.73M in Q4 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

Formula Growth held 239,208 shares of Alignment Healthcare worth $4.21M as of Q1 2026.
Formula Growth sold 300 Alignment Healthcare shares in Q1 2026, an estimated $6.03K.
Alignment Healthcare made up 1.9% of Formula Growth's portfolio in Q1 2026, its #7 holding.
Formula Growth first reported a position in Alignment Healthcare in Q4 2022 and has held it in 6 quarters since.
Formula Growth's Alignment Healthcare position peaked at $4.73M in Q4 2025.
293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Formula Growth's 13F filing for Q1 2026, filed 14 May 2026.